04:25 AM EDT, 03/20/2026 (MT Newswires) -- Sean A. McCarthy, Director and Chief Executive Officer, on March 17, 2026, sold 118,969 shares in Cytomx Therapeutics ( CTMX ) for $764,138. Following the Form 4 filing with the SEC, McCarthy has control over a total of 1,172,080 common shares of the company, with 1,078,922 shares held directly and 93,158 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1501989/000161071726000124/xslF345X05/form4.xml